Conidiobolomycosis in a young Malaysian woman showing chronic localized fibrosing leukocytoclastic vasculitis: a case report and meta-analysis focusing on clinicopathologic and therapeutic correlations with outcome

Conidiobolomycosis (also known as rhinoentomophthoramycosis) is a rare cutaneous/mucosal fungal infection seen mainly in the tropical rain forest regions of the world that can be associated with disfiguring facial elephantiasis, and rarely, death. To present an exemplary case report and perform a sy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of dermatopathology 2012-07, Vol.34 (5), p.511-522
Hauptverfasser: Choon, Siew-Eng, Kang, Justine, Neafie, Ronald C, Ragsdale, Bruce, Klassen-Fischer, Mary, Carlson, J Andrew
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 522
container_issue 5
container_start_page 511
container_title The American journal of dermatopathology
container_volume 34
creator Choon, Siew-Eng
Kang, Justine
Neafie, Ronald C
Ragsdale, Bruce
Klassen-Fischer, Mary
Carlson, J Andrew
description Conidiobolomycosis (also known as rhinoentomophthoramycosis) is a rare cutaneous/mucosal fungal infection seen mainly in the tropical rain forest regions of the world that can be associated with disfiguring facial elephantiasis, and rarely, death. To present an exemplary case report and perform a systematic review of the world's literature to more accurately describe the natural history and the effect of therapy on outcome in conidiobolomycosis. Case report and meta-analysis of published case reports and series of conidiobolomycosis to determine which clinical, pathologic, mycologic, and treatment factors impact on prognosis. We document delay in diagnosis of conidiobolomycosis in a young Malaysian woman, whose biopsy showed pathognomonic features-massive tissue eosinophilia and Splendore-Hoeppli phenomenon surrounding broad hyphae. These findings coexisted with granuloma faciale-like changes (fibrosing leukocytoclastic vasculitis) and lymphedema. Treatment with multiple antifungals was followed by complete resolution. For the meta-analysis, pooled data from 199 cases (162 with full outcome data) from 120 reports revealed a similar course for most cases: a disease affecting healthy young adults who present with progressive nasal symptoms (eg, nasal obstruction) and central facial swelling and show improvement or cure after surgical excision and/or treatment with one or more antifungal agents in 83%. Persistent-progressive facial disease occurred in 11%, and 6% died rapidly of fungal infection. Presentation with facial elephantiasis correlated with persistent-progressive rhinoentomophthoramycosis and a longer duration of disease before diagnosis (P = 0.02). Lethal infections were significantly associated with nonstereotypical presentation (eg, orbital cellulitis), visceral infection, absence of the Splendore-Hoeppli phenomenon, presence of comorbidities (eg, immunosuppression, hematolymphoid malignancy), infection with Conidiobolus incongruus or Conidiobolus lamprauges (not Conidiobolus coronatus), lack of response to amphotericin B, and female sex (all P ≤ 0.002). The few sensitivity studies performed demonstrated in vitro multidrug resistance of Conidiobolus species to most available antifungal agents. Publication bias, reporting heterogeneity, and data deficits may affect results. Conidiobolomycosis should be included in the differential diagnosis of patients who present with nasal symptoms and painless centrofacial swelling. Massive tissue eosinophilia
doi_str_mv 10.1097/DAD.0b013e31823db5c1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1022260006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1022260006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-3898e700a21b0e827dd9d37982b3dee449f5e6aaf09f89fcbaf8929c1c503f063</originalsourceid><addsrcrecordid>eNpdkUtv1TAQhS0EopfCP0DISzYpfty82FW3vKQiNrCOJs6kMTieYDu9Cj-U34NvW1iw8Uj2d84Z-TD2UooLKdr6zdXl1YXohdSoZaP00JdGPmI7WWpdCC3lY7YTstVFhuUZexbjdyGkakT5lJ0pVaumltWO_T6Qt4OlnhzNm6FoI7eeA99o9Tf8MzjYogXPjzTnM050tPneTCHrDHdkwNlfOPDR9iGr85vD9QeZLZFxEFOGbiGa1dlk49tsbCAiD7hQSBz8wGdMUIAHt52yRzLrnQt5bpzNGbRAmvJ2N9npxKcJAyy4npwNhYAOkiUf-dGmidOaDM34nD0ZwUV88TDP2bf3774ePhbXXz58OlxeF0aVVSp00zZYCwFK9gIbVQ9DO-i6bVSvB8T9vh1LrABG0Y5NO5oe8lCtkaYUehSVPmev732XQD9XjKmbbTToHHikNXZSKKUqIe7Q_T1q8j_FgGO3BDtD2DLUnRrtcqPd_41m2auHhLWfcfgn-luh_gNEwqW1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1022260006</pqid></control><display><type>article</type><title>Conidiobolomycosis in a young Malaysian woman showing chronic localized fibrosing leukocytoclastic vasculitis: a case report and meta-analysis focusing on clinicopathologic and therapeutic correlations with outcome</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Choon, Siew-Eng ; Kang, Justine ; Neafie, Ronald C ; Ragsdale, Bruce ; Klassen-Fischer, Mary ; Carlson, J Andrew</creator><creatorcontrib>Choon, Siew-Eng ; Kang, Justine ; Neafie, Ronald C ; Ragsdale, Bruce ; Klassen-Fischer, Mary ; Carlson, J Andrew</creatorcontrib><description>Conidiobolomycosis (also known as rhinoentomophthoramycosis) is a rare cutaneous/mucosal fungal infection seen mainly in the tropical rain forest regions of the world that can be associated with disfiguring facial elephantiasis, and rarely, death. To present an exemplary case report and perform a systematic review of the world's literature to more accurately describe the natural history and the effect of therapy on outcome in conidiobolomycosis. Case report and meta-analysis of published case reports and series of conidiobolomycosis to determine which clinical, pathologic, mycologic, and treatment factors impact on prognosis. We document delay in diagnosis of conidiobolomycosis in a young Malaysian woman, whose biopsy showed pathognomonic features-massive tissue eosinophilia and Splendore-Hoeppli phenomenon surrounding broad hyphae. These findings coexisted with granuloma faciale-like changes (fibrosing leukocytoclastic vasculitis) and lymphedema. Treatment with multiple antifungals was followed by complete resolution. For the meta-analysis, pooled data from 199 cases (162 with full outcome data) from 120 reports revealed a similar course for most cases: a disease affecting healthy young adults who present with progressive nasal symptoms (eg, nasal obstruction) and central facial swelling and show improvement or cure after surgical excision and/or treatment with one or more antifungal agents in 83%. Persistent-progressive facial disease occurred in 11%, and 6% died rapidly of fungal infection. Presentation with facial elephantiasis correlated with persistent-progressive rhinoentomophthoramycosis and a longer duration of disease before diagnosis (P = 0.02). Lethal infections were significantly associated with nonstereotypical presentation (eg, orbital cellulitis), visceral infection, absence of the Splendore-Hoeppli phenomenon, presence of comorbidities (eg, immunosuppression, hematolymphoid malignancy), infection with Conidiobolus incongruus or Conidiobolus lamprauges (not Conidiobolus coronatus), lack of response to amphotericin B, and female sex (all P ≤ 0.002). The few sensitivity studies performed demonstrated in vitro multidrug resistance of Conidiobolus species to most available antifungal agents. Publication bias, reporting heterogeneity, and data deficits may affect results. Conidiobolomycosis should be included in the differential diagnosis of patients who present with nasal symptoms and painless centrofacial swelling. Massive tissue eosinophilia and Splendore-Hoeppli material coating thin-walled hyphae confirms the clinical diagnosis. The granuloma faciale-like histology found in this case can explain the onset of facial lymphedema by fibroinflammatory destruction of lymphatic vessels; the duration of disease and severity of inflammation likely predicts whether the lymphedema is reversible or not. Although rhinoentomophthoramycosis ostensibly responds in vivo to most available antifungal agents, routine culture and susceptibility testing is recommended to better define the efficacy of these therapeutic agents.</description><identifier>ISSN: 0193-1091</identifier><identifier>EISSN: 1533-0311</identifier><identifier>DOI: 10.1097/DAD.0b013e31823db5c1</identifier><identifier>PMID: 22728716</identifier><language>eng</language><publisher>United States</publisher><subject>Adolescent ; Adult ; Antifungal Agents - therapeutic use ; Biopsy ; Child, Preschool ; Chronic Disease ; Conidiobolus - isolation &amp; purification ; Elephantiasis - diagnosis ; Elephantiasis - drug therapy ; Elephantiasis - microbiology ; Elephantiasis - pathology ; Face ; Female ; Fibrosis ; Humans ; Infant ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Skin - microbiology ; Skin - pathology ; Time Factors ; Treatment Outcome ; Vasculitis, Leukocytoclastic, Cutaneous - diagnosis ; Vasculitis, Leukocytoclastic, Cutaneous - drug therapy ; Vasculitis, Leukocytoclastic, Cutaneous - microbiology ; Vasculitis, Leukocytoclastic, Cutaneous - pathology ; Young Adult ; Zygomycosis - diagnosis ; Zygomycosis - drug therapy ; Zygomycosis - microbiology ; Zygomycosis - pathology</subject><ispartof>The American journal of dermatopathology, 2012-07, Vol.34 (5), p.511-522</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-3898e700a21b0e827dd9d37982b3dee449f5e6aaf09f89fcbaf8929c1c503f063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22728716$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Choon, Siew-Eng</creatorcontrib><creatorcontrib>Kang, Justine</creatorcontrib><creatorcontrib>Neafie, Ronald C</creatorcontrib><creatorcontrib>Ragsdale, Bruce</creatorcontrib><creatorcontrib>Klassen-Fischer, Mary</creatorcontrib><creatorcontrib>Carlson, J Andrew</creatorcontrib><title>Conidiobolomycosis in a young Malaysian woman showing chronic localized fibrosing leukocytoclastic vasculitis: a case report and meta-analysis focusing on clinicopathologic and therapeutic correlations with outcome</title><title>The American journal of dermatopathology</title><addtitle>Am J Dermatopathol</addtitle><description>Conidiobolomycosis (also known as rhinoentomophthoramycosis) is a rare cutaneous/mucosal fungal infection seen mainly in the tropical rain forest regions of the world that can be associated with disfiguring facial elephantiasis, and rarely, death. To present an exemplary case report and perform a systematic review of the world's literature to more accurately describe the natural history and the effect of therapy on outcome in conidiobolomycosis. Case report and meta-analysis of published case reports and series of conidiobolomycosis to determine which clinical, pathologic, mycologic, and treatment factors impact on prognosis. We document delay in diagnosis of conidiobolomycosis in a young Malaysian woman, whose biopsy showed pathognomonic features-massive tissue eosinophilia and Splendore-Hoeppli phenomenon surrounding broad hyphae. These findings coexisted with granuloma faciale-like changes (fibrosing leukocytoclastic vasculitis) and lymphedema. Treatment with multiple antifungals was followed by complete resolution. For the meta-analysis, pooled data from 199 cases (162 with full outcome data) from 120 reports revealed a similar course for most cases: a disease affecting healthy young adults who present with progressive nasal symptoms (eg, nasal obstruction) and central facial swelling and show improvement or cure after surgical excision and/or treatment with one or more antifungal agents in 83%. Persistent-progressive facial disease occurred in 11%, and 6% died rapidly of fungal infection. Presentation with facial elephantiasis correlated with persistent-progressive rhinoentomophthoramycosis and a longer duration of disease before diagnosis (P = 0.02). Lethal infections were significantly associated with nonstereotypical presentation (eg, orbital cellulitis), visceral infection, absence of the Splendore-Hoeppli phenomenon, presence of comorbidities (eg, immunosuppression, hematolymphoid malignancy), infection with Conidiobolus incongruus or Conidiobolus lamprauges (not Conidiobolus coronatus), lack of response to amphotericin B, and female sex (all P ≤ 0.002). The few sensitivity studies performed demonstrated in vitro multidrug resistance of Conidiobolus species to most available antifungal agents. Publication bias, reporting heterogeneity, and data deficits may affect results. Conidiobolomycosis should be included in the differential diagnosis of patients who present with nasal symptoms and painless centrofacial swelling. Massive tissue eosinophilia and Splendore-Hoeppli material coating thin-walled hyphae confirms the clinical diagnosis. The granuloma faciale-like histology found in this case can explain the onset of facial lymphedema by fibroinflammatory destruction of lymphatic vessels; the duration of disease and severity of inflammation likely predicts whether the lymphedema is reversible or not. Although rhinoentomophthoramycosis ostensibly responds in vivo to most available antifungal agents, routine culture and susceptibility testing is recommended to better define the efficacy of these therapeutic agents.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Biopsy</subject><subject>Child, Preschool</subject><subject>Chronic Disease</subject><subject>Conidiobolus - isolation &amp; purification</subject><subject>Elephantiasis - diagnosis</subject><subject>Elephantiasis - drug therapy</subject><subject>Elephantiasis - microbiology</subject><subject>Elephantiasis - pathology</subject><subject>Face</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Humans</subject><subject>Infant</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Skin - microbiology</subject><subject>Skin - pathology</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Vasculitis, Leukocytoclastic, Cutaneous - diagnosis</subject><subject>Vasculitis, Leukocytoclastic, Cutaneous - drug therapy</subject><subject>Vasculitis, Leukocytoclastic, Cutaneous - microbiology</subject><subject>Vasculitis, Leukocytoclastic, Cutaneous - pathology</subject><subject>Young Adult</subject><subject>Zygomycosis - diagnosis</subject><subject>Zygomycosis - drug therapy</subject><subject>Zygomycosis - microbiology</subject><subject>Zygomycosis - pathology</subject><issn>0193-1091</issn><issn>1533-0311</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUtv1TAQhS0EopfCP0DISzYpfty82FW3vKQiNrCOJs6kMTieYDu9Cj-U34NvW1iw8Uj2d84Z-TD2UooLKdr6zdXl1YXohdSoZaP00JdGPmI7WWpdCC3lY7YTstVFhuUZexbjdyGkakT5lJ0pVaumltWO_T6Qt4OlnhzNm6FoI7eeA99o9Tf8MzjYogXPjzTnM050tPneTCHrDHdkwNlfOPDR9iGr85vD9QeZLZFxEFOGbiGa1dlk49tsbCAiD7hQSBz8wGdMUIAHt52yRzLrnQt5bpzNGbRAmvJ2N9npxKcJAyy4npwNhYAOkiUf-dGmidOaDM34nD0ZwUV88TDP2bf3774ePhbXXz58OlxeF0aVVSp00zZYCwFK9gIbVQ9DO-i6bVSvB8T9vh1LrABG0Y5NO5oe8lCtkaYUehSVPmev732XQD9XjKmbbTToHHikNXZSKKUqIe7Q_T1q8j_FgGO3BDtD2DLUnRrtcqPd_41m2auHhLWfcfgn-luh_gNEwqW1</recordid><startdate>201207</startdate><enddate>201207</enddate><creator>Choon, Siew-Eng</creator><creator>Kang, Justine</creator><creator>Neafie, Ronald C</creator><creator>Ragsdale, Bruce</creator><creator>Klassen-Fischer, Mary</creator><creator>Carlson, J Andrew</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201207</creationdate><title>Conidiobolomycosis in a young Malaysian woman showing chronic localized fibrosing leukocytoclastic vasculitis: a case report and meta-analysis focusing on clinicopathologic and therapeutic correlations with outcome</title><author>Choon, Siew-Eng ; Kang, Justine ; Neafie, Ronald C ; Ragsdale, Bruce ; Klassen-Fischer, Mary ; Carlson, J Andrew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-3898e700a21b0e827dd9d37982b3dee449f5e6aaf09f89fcbaf8929c1c503f063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Biopsy</topic><topic>Child, Preschool</topic><topic>Chronic Disease</topic><topic>Conidiobolus - isolation &amp; purification</topic><topic>Elephantiasis - diagnosis</topic><topic>Elephantiasis - drug therapy</topic><topic>Elephantiasis - microbiology</topic><topic>Elephantiasis - pathology</topic><topic>Face</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Humans</topic><topic>Infant</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Skin - microbiology</topic><topic>Skin - pathology</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Vasculitis, Leukocytoclastic, Cutaneous - diagnosis</topic><topic>Vasculitis, Leukocytoclastic, Cutaneous - drug therapy</topic><topic>Vasculitis, Leukocytoclastic, Cutaneous - microbiology</topic><topic>Vasculitis, Leukocytoclastic, Cutaneous - pathology</topic><topic>Young Adult</topic><topic>Zygomycosis - diagnosis</topic><topic>Zygomycosis - drug therapy</topic><topic>Zygomycosis - microbiology</topic><topic>Zygomycosis - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Choon, Siew-Eng</creatorcontrib><creatorcontrib>Kang, Justine</creatorcontrib><creatorcontrib>Neafie, Ronald C</creatorcontrib><creatorcontrib>Ragsdale, Bruce</creatorcontrib><creatorcontrib>Klassen-Fischer, Mary</creatorcontrib><creatorcontrib>Carlson, J Andrew</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of dermatopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Choon, Siew-Eng</au><au>Kang, Justine</au><au>Neafie, Ronald C</au><au>Ragsdale, Bruce</au><au>Klassen-Fischer, Mary</au><au>Carlson, J Andrew</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conidiobolomycosis in a young Malaysian woman showing chronic localized fibrosing leukocytoclastic vasculitis: a case report and meta-analysis focusing on clinicopathologic and therapeutic correlations with outcome</atitle><jtitle>The American journal of dermatopathology</jtitle><addtitle>Am J Dermatopathol</addtitle><date>2012-07</date><risdate>2012</risdate><volume>34</volume><issue>5</issue><spage>511</spage><epage>522</epage><pages>511-522</pages><issn>0193-1091</issn><eissn>1533-0311</eissn><abstract>Conidiobolomycosis (also known as rhinoentomophthoramycosis) is a rare cutaneous/mucosal fungal infection seen mainly in the tropical rain forest regions of the world that can be associated with disfiguring facial elephantiasis, and rarely, death. To present an exemplary case report and perform a systematic review of the world's literature to more accurately describe the natural history and the effect of therapy on outcome in conidiobolomycosis. Case report and meta-analysis of published case reports and series of conidiobolomycosis to determine which clinical, pathologic, mycologic, and treatment factors impact on prognosis. We document delay in diagnosis of conidiobolomycosis in a young Malaysian woman, whose biopsy showed pathognomonic features-massive tissue eosinophilia and Splendore-Hoeppli phenomenon surrounding broad hyphae. These findings coexisted with granuloma faciale-like changes (fibrosing leukocytoclastic vasculitis) and lymphedema. Treatment with multiple antifungals was followed by complete resolution. For the meta-analysis, pooled data from 199 cases (162 with full outcome data) from 120 reports revealed a similar course for most cases: a disease affecting healthy young adults who present with progressive nasal symptoms (eg, nasal obstruction) and central facial swelling and show improvement or cure after surgical excision and/or treatment with one or more antifungal agents in 83%. Persistent-progressive facial disease occurred in 11%, and 6% died rapidly of fungal infection. Presentation with facial elephantiasis correlated with persistent-progressive rhinoentomophthoramycosis and a longer duration of disease before diagnosis (P = 0.02). Lethal infections were significantly associated with nonstereotypical presentation (eg, orbital cellulitis), visceral infection, absence of the Splendore-Hoeppli phenomenon, presence of comorbidities (eg, immunosuppression, hematolymphoid malignancy), infection with Conidiobolus incongruus or Conidiobolus lamprauges (not Conidiobolus coronatus), lack of response to amphotericin B, and female sex (all P ≤ 0.002). The few sensitivity studies performed demonstrated in vitro multidrug resistance of Conidiobolus species to most available antifungal agents. Publication bias, reporting heterogeneity, and data deficits may affect results. Conidiobolomycosis should be included in the differential diagnosis of patients who present with nasal symptoms and painless centrofacial swelling. Massive tissue eosinophilia and Splendore-Hoeppli material coating thin-walled hyphae confirms the clinical diagnosis. The granuloma faciale-like histology found in this case can explain the onset of facial lymphedema by fibroinflammatory destruction of lymphatic vessels; the duration of disease and severity of inflammation likely predicts whether the lymphedema is reversible or not. Although rhinoentomophthoramycosis ostensibly responds in vivo to most available antifungal agents, routine culture and susceptibility testing is recommended to better define the efficacy of these therapeutic agents.</abstract><cop>United States</cop><pmid>22728716</pmid><doi>10.1097/DAD.0b013e31823db5c1</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0193-1091
ispartof The American journal of dermatopathology, 2012-07, Vol.34 (5), p.511-522
issn 0193-1091
1533-0311
language eng
recordid cdi_proquest_miscellaneous_1022260006
source MEDLINE; Journals@Ovid Complete
subjects Adolescent
Adult
Antifungal Agents - therapeutic use
Biopsy
Child, Preschool
Chronic Disease
Conidiobolus - isolation & purification
Elephantiasis - diagnosis
Elephantiasis - drug therapy
Elephantiasis - microbiology
Elephantiasis - pathology
Face
Female
Fibrosis
Humans
Infant
Magnetic Resonance Imaging
Male
Middle Aged
Skin - microbiology
Skin - pathology
Time Factors
Treatment Outcome
Vasculitis, Leukocytoclastic, Cutaneous - diagnosis
Vasculitis, Leukocytoclastic, Cutaneous - drug therapy
Vasculitis, Leukocytoclastic, Cutaneous - microbiology
Vasculitis, Leukocytoclastic, Cutaneous - pathology
Young Adult
Zygomycosis - diagnosis
Zygomycosis - drug therapy
Zygomycosis - microbiology
Zygomycosis - pathology
title Conidiobolomycosis in a young Malaysian woman showing chronic localized fibrosing leukocytoclastic vasculitis: a case report and meta-analysis focusing on clinicopathologic and therapeutic correlations with outcome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A32%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conidiobolomycosis%20in%20a%20young%20Malaysian%20woman%20showing%20chronic%20localized%20fibrosing%20leukocytoclastic%20vasculitis:%20a%20case%20report%20and%20meta-analysis%20focusing%20on%20clinicopathologic%20and%20therapeutic%20correlations%20with%20outcome&rft.jtitle=The%20American%20journal%20of%20dermatopathology&rft.au=Choon,%20Siew-Eng&rft.date=2012-07&rft.volume=34&rft.issue=5&rft.spage=511&rft.epage=522&rft.pages=511-522&rft.issn=0193-1091&rft.eissn=1533-0311&rft_id=info:doi/10.1097/DAD.0b013e31823db5c1&rft_dat=%3Cproquest_cross%3E1022260006%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1022260006&rft_id=info:pmid/22728716&rfr_iscdi=true